Teflaro FDA Approval History
FDA Approved: Yes (First approved October 29, 2010)
Brand name: Teflaro
Generic name: ceftaroline fosamil
Dosage form: Injection
Company: Allergan plc
Treatment for: Pneumonia, Skin and Structure Infection
Teflaro (ceftaroline fosamil) is a cephalosporin antibacterial indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).
Development timeline for Teflaro
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.